Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Read the Original
This page is a summary of: A phase 1, randomized, placebo-controlled, dose-escalation study of an anti-IL-13 monoclonal antibody in healthy subjects and mild asthmatics, British Journal of Clinical Pharmacology, December 2012, Wiley, DOI: 10.1111/j.1365-2125.2012.04334.x.
You can read the full text:
Be the first to contribute to this page